Henrik Ancher-Jensen
Corporate Officer/Principal at AGILENT TECHNOLOGIES, INC.
Net worth: 8 M $ as of 2024-03-30
Profile
Henrik Ancher-Jensen is currently working as the SVP & President-Order Fulfillment & Supply Chain at Agilent Technologies, Inc. He previously worked as the Vice President-Global Operations at Dako Denmark ApS from 2010 to 2012.
Mr. Ancher-Jensen completed his undergraduate degree at the University of Aarhus.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-01-22 | 54,713 ( 0.02% ) | 8 M $ | 2024-03-30 |
Henrik Ancher-Jensen active positions
Companies | Position | Start |
---|---|---|
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | 2012-08-31 |
Former positions of Henrik Ancher-Jensen
Companies | Position | End |
---|---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Chief Operating Officer | 2012-08-31 |
Training of Henrik Ancher-Jensen
University of Aarhus | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
Private companies | 1 |
---|---|
Dako Denmark ApS
Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Health Technology |
- Stock Market
- Insiders
- Henrik Ancher-Jensen